WHO ICTRP trial
Clinical Study for Sequential Chemotherapy with Apatinib in Patients with…
ChiCTR1900024189 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900024189 |
|---|---|
| Public title | Clinical Study for Sequential Chemotherapy with Apatinib in Patients with Non-small Cell Lung Cancer |
| Scientific title | Clinical Study for Sequential Chemotherapy with Apatinib in Patients with Non-small Cell Lung Cancer |
| Primary sponsor | Shanxi Provincial Hospital of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | lung cancer |
| Interventions | Experimental group:Apatinib Combined with Docetaxel;control group:Docetaxel |
| Registration date | Jun 29, 2019 |
| Target size | Experimental group:30;control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: